SCHEMBL10370855

SCHEMBL10370855

CN(C)Cc1ccc(N/C(=C2\C(=O)Nc3cc(C#CC(N)=O)ccc32)c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 9/20 0.39
CYP3A4 P08684 2/20 0.37
MAP2K1 Q02750 2/20 0.36
RET P07949 2/20 0.36
CDC7 O00311 1/20 0.36
PLK4 O00444 1/20 0.36
AURKA O14965 1/20 0.36
RPS6KA4 O75676 1/20 0.36
CDKL5 O76039 1/20 0.36
STK10 O94804 1/20 0.36
LATS1 O95835 1/20 0.36
ABL1 P00519 1/20 0.36
LCK P06239 1/20 0.36
FYN P06241 1/20 0.36
YES1 P07947 1/20 0.36
LYN P07948 1/20 0.36
HCK P08631 1/20 0.36
PDGFRB P09619 1/20 0.36
FGFR1 P11362 1/20 0.36
SRC P12931 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10293630 0.91 MAP2K1 (0.40) ROCK2CYP3A4MAP2K1RETCDC7
SCHEMBL10325117 0.91 MAP2K1 (0.40) ROCK2CYP3A4MAP2K1RETCDC7
SCHEMBL26907228 0.89 MAP2K1 (0.48) ROCK2CYP3A4MAP2K1RETCDC7
SCHEMBL10326049 0.89 MAP2K1 (0.48) ROCK2CYP3A4MAP2K1RETCDC7
SCHEMBL4081822 0.89 MAP2K1 (0.48) ROCK2CYP3A4MAP2K1RETCDC7
SCHEMBL10364455 0.89 MAP2K1 (0.38) ROCK2CYP3A4MAP2K1RETCDC7
SCHEMBL10324778 0.89 MAP2K1 (0.38) ROCK2CYP3A4MAP2K1RETCDC7
SCHEMBL10325557 0.88 MAP2K1 (0.40) ROCK2CYP3A4MAP2K1RETCDC7
SCHEMBL12237872 0.88 MAP2K1 (0.40) ROCK2CYP3A4MAP2K1RETCDC7
SCHEMBL15427656 0.88 MAP2K1 (0.40) ROCK2CYP3A4MAP2K1RETCDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012095505-A1 ANTICANCER THERAPY WITH DUAL AURORA KINASE / MEK INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-07-19 WO disclosed